Twist Bioscience(FRA) 0ME

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

$0.00

+0.00%

+0.00Today

Twist Bioscience Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$370.26

Net Income (TTM)

-$117.21

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

0ME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Twist Bioscience

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. Its products include genes, oligo pools, Next Generation Sequencing (NGS), variant libraries, synthetic controls, antibody discovery, and SARS-CoV-2 Tools. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment consists of Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.

Industry

Biotechnology

Sector

Health Care

Employees

979

CEO

Emily Marine Leproust, PhD

Website

www.twistbioscience.com

0ME Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Twist Bioscience Performance Analysis

Twist Bioscience annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-09-30	USD 188,238,763	70.0%
2023	2023-09-30	USD 229,959,806	22.2%
2024	2024-09-30	USD 288,731,362	25.6%
2025	2025-09-30	USD 341,085,748	18.1%

Twist Bioscience annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-09-30	USD -3.74	41.7%
2023	2023-09-30	USD -3.37	-9.7%
2024	2024-09-30	USD -3.32	-1.6%
2025	2025-09-30	USD -1.18	-64.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$101.81

+1.2%

Gross Profit

$53.71

+1.2%

Gross Margin

52.76%

+1.0%

Market Cap

N/A

Market Cap/Employee

$5.43

N/A

Employees

979

N/A

Net Income

-$30.15

-1.7%

EBITDA

-$25.37

+1.2%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$184.58

-22.5%

Total Debt

$81.86

+1.2%

Accounts Receivable

$56.90

+1.3%

Inventory

$30.75

+1.4%

Long Term Debt

$74.31

+1.4%

Short Term Debt

$7.55

+0.6%

Return on Assets

-20.63%

+1.5%

Return on Invested Capital

-25.98%

+0.8%

Free Cash Flow

-$7.76

+1.2%

Operating Cash Flow

$0.73

+0.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 0ME

What is the current price of Twist Bioscience?

Twist Bioscience is trading at N/A per share.

What is the 52-week range for Twist Bioscience?

Over the past 52 weeks, Twist Bioscience has traded between N/A and N/A.

How much debt does Twist Bioscience have?

As of the most recent reporting period, Twist Bioscience reported total debt of $81.86M.

How much cash does Twist Bioscience have on hand?

Twist Bioscience reported $102.72M in cash and cash equivalents in its most recent financial results.

What is Twist Bioscience’s dividend yield?

Twist Bioscience does not currently have a dividend yield.

Twist Bioscience(FRA) 0ME

Twist Bioscience Financials at a Glance

0ME News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Twist Bioscience

0ME Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Twist Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 0ME

What is the current price of Twist Bioscience?

What is the 52-week range for Twist Bioscience?

How much debt does Twist Bioscience have?

How much cash does Twist Bioscience have on hand?

What is Twist Bioscience’s dividend yield?

Premium Investing Services